Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome

Publisher： Karger

E-ISSN： 1421-9662|134|1|40-48

ISSN： 0001-5792

Source： Acta Haematologica, Vol.134, Iss.1, 2015-06, pp. : 40-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Transfusion-Associated Iron Overload as an Adverse Risk Factor for Transplantation Outcome in Patients Undergoing Reduced-Intensity Stem Cell Transplantation for Myeloid Malignancies

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-01 ,pp. : 182-189

Karger

Access to resources Recommend Favorite

Retrospective Multicenter Study of Allogeneic Peripheral Blood Stem Cell Transplantation Followed by Reduced-Intensity Conditioning or Conventional Myeloablative Regimen

By  

Acta Haematologica, Vol. 113, Iss. 4, 2005-06 ,pp. : 220-227

Karger

Access to resources Recommend Favorite

Allogeneic haematopoietic cell transplantation with reduced‐intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 3, 2015-02 ,pp. : 463-466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of graft‐versus‐host disease in reduced‐intensity stem cell transplantation (RIST) for patients with haematological malignancies

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 121, Iss. 2, 2003-04 ,pp. : 296-303

John Wiley & Sons Inc

Access to resources Recommend Favorite